At 16.2% of CAGR, In Vitro Lung Model Market is Growing $701.81 Million by 2027 – InSphero, Emulate, AlveoliX AG, Thermo Fisher Scientific, PromoCell GmbH, Merck KGaA

According to a new market research study of ‘In vitro lung model to 2027 – Global Analysis and Forecasts by Type, and Application.’ The global in vitro lung model market is anticipated to reach US$ 701.81 Mn in 2027 from US$ 185.80 Mn in 2018. The market is anticipated to grow with a CAGR of 16.2% from 2019-2027. The report provides the trends prevailing in the global in vitro lung model market and the factors driving the market along with those that act as hindrances.

Driving factors of the in vitro lung model are significant growth in research funding, and increasing adoption of 3d model systems for in vitro studies. Also, growing research on lung diseases is likely to have a positive impact on the growth of the market in the coming years. Besides, rising healthcare expenditure, and advancements in cell culture techniques is likely to have a positive effect on the growth of the market in the forecast years.

Get Sample PDF Copy at

The cases of asthma, lung cancer, and COPD has been growing across the globe at a significant rate. Thus there is a growing need to study lung diseases specifically. Since early 2010’s the practices of creating lab-grown organ buds, mostly referred to as ‘organoids’, have become more popular. These organ buds are miniature organ-like structures that are maintained in the lab, and researchers are able to grow these organoids, which resembles human body tissues. Lung diseases, like idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD), is a significant cause of death and illness worldwide. A recently published report by Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at the University of California developed a new system for building lung 3D organoids to model lung disease. Moreover, Lung cancer cell lines have made a significant contribution to lung cancer research and biomedical discovery. The high similarities between lung cancer cell lines and the lung tumor helps in discovering new drug molecules. Thus the growing research on lung diseases is expected to offer broad growth opportunities for the in vitro lung model market at the global level.

The global in vitro lung model market is segmented by type, and application. On the basis of type, the market is segmented into 2D and 3D. The 3D segment  is expected to dominate the type segment market as 3D cell culture gives better  phenotypes insights which are poorly reproduced in conventional 2D cell culture, Based on the application, market is segmented into drug screening, toxicology, 3d model development, physiologic research, stem cell research, and regenerative medicine. Toxicology segment is expected to dominate the application segment during the forecast period.

Some of the important primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization (WHO), American Society of Clinical Oncology, American Type Culture Collection, Centers for Disease Control and Prevention, Canadian Lung Association and others.

Buy Complete Report at

About Us – The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact us –

Phone : +1-646-491-9876

Email Id : [email protected]



Related Articles